ProPhase Labs to Present at the Planet MicroCap Showcase 2022 on Wednesday, May 4, 2022
April 27, 2022 08:15 ET
|
ProPhase Labs, Inc.
Garden City, NY, April 27, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present...
ProPhase Labs Announces Record Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021
March 30, 2022 08:30 ET
|
ProPhase Labs, Inc.
Record Financial Results also expected for Q1 2022 Company to hold a conference call March 30, 2022, at 11:00AM ET Garden City, NY, March 30, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs,...
ProPhase Labs to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Wednesday, March 30, 2022 at 11:00 a.m. Eastern Time
March 24, 2022 08:15 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, March 24, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified company offering a range of services including diagnostic testing, genomics testing and contract...
ProPhase Labs Announces Special Cash Dividend
February 16, 2022 08:15 ET
|
ProPhase Labs, Inc.
Anticipates Record Q4 2021 and Q1 2022 Revenues and Profits Garden City, NY, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company,...
ProPhase Labs to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Conference
February 03, 2022 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Feb. 03, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
ProPhase Labs Announces Record COVID-19 Testing in Q4 2021
January 13, 2022 08:15 ET
|
ProPhase Labs, Inc.
Q1 2022 Testing Volumes will Significantly Exceed Previous Record Results from Q1 2021 Significant year-over-year growth expected for the next four quarters Garden City, NY, Jan. 13, 2022 (GLOBE...
ProPhase Labs to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference
January 05, 2022 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 05, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present a...
ProPhase Labs Continues to Build Strong Leadership with Key Promotions and Additions to Management Team
December 16, 2021 08:30 ET
|
ProPhase Labs, Inc.
Precision Medicine division adds Industry Veteran Sam A. Beeler as Chief Strategy Officer; Diagnostics Division Promotes Alice Lioi and Jason Karkus to EVP and Co-Chief Operating Officers and Sergio...
PROPHASE LABS, INC. ANNOUNCES INDUCEMENT AWARD UNDER NASDAQ LISTING RULE 5635(C)(4)
November 23, 2021 16:15 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 23, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that it has granted an inducement award to a new...
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2021
November 12, 2021 08:30 ET
|
ProPhase Labs, Inc.
Company to hold a conference call November 12, 2021 at 11:00AM ET Garden City, NY, Nov. 12, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics...